Perminder S. Sachdev

Perminder S. Sachdev

MBBS, MD, PhD, FRANZCP, FAAHMS

Neurologist

Over 40 years Experience

📍 Randwick

About of Perminder S. Sachdev

Perminder S. Sachdev is a neurologist based in Barker Street, Randwick, NSW 2031, Australia.


Neurology is about the brain, nerves, and how they work together. Dr Sachdev looks after people with long-term and sudden problems that affect thinking, movement, and feeling. In many cases, this includes memory issues and dementia, such as Alzheimer’s disease, vascular dementia, and Lewy body dementia. At times, it also involves delirium, attention and learning concerns, and other changes in thinking that can be hard to explain.


Dr Sachdev also works with patients who have had strokes or transient ischaemic attacks (TIAs). These are the “warning” events that can come before a bigger stroke, so getting support early matters. Neurological care can also include conditions like movement disorders, including Parkinson’s disease, and other issues that affect muscles and movement.


Another big part of the practice is seizures and epilepsy. This can cover different seizure types, including absence seizures and generalised tonic-clonic seizures, as well as related problems like drug-induced dyskinesia. For people with ongoing neurological symptoms, the goal is often to work out what’s going on and help keep day-to-day life as steady as possible.


Over time, Dr Sachdev has also gained experience with motor neuron conditions, including amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), and with other rare brain and nerve conditions. There are also areas like encephalitis and other brain inflammation problems, plus some genetic or inherited conditions that affect the brain and nerves.


Experience-wise, Dr Sachdev has over 40 years of experience. That kind of time in the job helps when cases are complex, family questions come up often, or symptoms change as treatment goes on.


Education and training include an MBBS, and further specialist qualifications such as MD in Psychiatry and a PhD in Psychiatry. Dr Sachdev also holds FRANZCP (Fellow of the Royal Australian and New Zealand College of Psychiatrists) and FAAHMS (Fellow of the Australian Academy of Health and Medical Sciences). The medical training included time with the All India Institute of Medical Sciences (AIIMS) in New Delhi, as well as PhD work through the University of New South Wales in Australia.


Research and clinical trials: there is information about published work, but no specific details about current or past clinical trials here.


The focus stays practical—clear explanations, careful checks, and support for both the patient and their family as the condition is understood and managed.

Education

  • MBBS; All India Institute of Medical Sciences (AIIMS), New Delhi, India; 1978
  • MD in Psychiatry; AIIMS, New Delhi; 1983
  • PhD in Psychiatry; University of New South Wales, Australia; 1991
  • FRANZCP: Fellow of the Royal Australian and New Zealand College of Psychiatrists
  • FAAHMS: Fellow of the Australian Academy of Health and Medical Sciences

Services & Conditions Treated

Alzheimer's DiseaseDementiaCACH SyndromeDevelopmental Dysphasia FamilialMemory LossVascular DementiaAmyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and LeukoencephalopathyFolate-Deficiency AnemiaHypertensionMovement DisordersObesityPrimary Lateral SclerosisStrokeAbdominal Obesity Metabolic SyndromeAbsence SeizureAnemiaAnorexiaAnti-NMDA Receptor EncephalitisAstrocytomaAttention Deficit Hyperactivity Disorder (ADHD)Autism Spectrum DisorderBipolar Disorder (BPD)Cerebral Amyloid AngiopathyChildhood Iron Deficiency AnemiaDeep Brain StimulationDeliriumDrug Induced DyskinesiaEncephalitisEpilepsyFolate DeficiencyGeneralized Tonic-Clonic SeizureGliomaGliomatosis CerebriHearing LossHigh CholesterolIncreased Head CircumferenceIron Deficiency AnemiaLewy Body Dementia (LBD)Major DepressionMalnutritionMetabolic SyndromeMorgagni-Stewart-Morel SyndromeMuscle AtrophyNeurotoxicity SyndromesObesity in ChildrenObsessive-Compulsive Disorder (OCD)Parkinson's DiseasePrimary AmyloidosisRenal Cell Carcinoma (RCC)SchizophreniaSeizuresTourette SyndromeTransient Ischemic Attack (TIA)Transient Tic DisorderType 2 Diabetes (T2D)Vitamin B12 Deficiency AnemiaVitamin D Deficiency

Publications

5 total
A longitudinal investigation of the relationship between dimensional psychopathology, gray matter structure, and dementia status in older adulthood.

Psychological medicine • February 04, 2025

Nicholas Hoy, Monika Waszczuk, Matthew Sunderland, Samantha Lynch, Perminder Sachdev, Henry Brodaty, Simone Reppermund, Louise Mewton

Background: The structure of psychopathology can be organized hierarchically into a set of transdiagnostic dimensional phenotypes. No studies have examined whether these phenotypes are associated with brain structure or dementia in older adults. Methods: Data were drawn from a longitudinal study of older adults aged 70-90 years at baseline (N = 1072; 44.8% male). Confirmatory factor models were fit to baseline psychiatric symptoms, with model fit assessed via traditional fit indices, model-based reliability estimates, and evaluation of model parameters. Bayesian plausible values were generated from the best-fitting model for use in subsequent analyses. Linear mixed models examined intraindividual change in global and regional gray matter volume (GMV) and cortical thickness over 6 years. Logistic regression examined whether symptom dimensions predicted incident dementia over 12 years. Results: A higher-order model showed a good fit to the data (BIC = 28,691.85; ssaBIC = 28,396.47; CFI = 0.926; TLI = 0.92; RMSEA = 0.047), including a general factor and lower-order dimensions of internalizing, disinhibited externalizing, and substance use. Baseline symptom dimensions did not predict change over time in total cortical and subcortical GMV or average cortical thickness; regional GMV or cortical thickness in the frontal, parietal, temporal, or occipital lobes; or regional GMV in the hippocampus and cerebellum (all p-values >0.5). Finally, baseline symptom dimensions did not predict incident dementia across follow-ups (all p-values >0.5). Conclusions: We found no evidence that transdiagnostic dimensions are associated with gray matter structure or dementia in older adults. Future research should examine these relationships using psychiatric indicators capturing past history of chronic mental illness rather than current symptoms.

Apathy is distinct from depression or fatigue and is associated with poor physical health in an older community cohort.

International Psychogeriatrics • April 04, 2025

Fleur Harrison, Moyra Mortby, Andrew Lloyd, Adam Guastella, Julian Trollor, Perminder Sachdev, Henry Brodaty

Objective: To estimate point prevalence of apathy in older adults, examine its overlap with depression and fatigue, and explore its associations with multimorbidity and objective markers of health. Methods: Sydney Memory and Ageing Study, an Australian population-based cohort. Methods: Community dwellings between 2005-2007. Methods: 1,030 older adults, without dementia, aged 70-90. Methods: Apathy was classified using strict (=3) and standard (≥2) cutoff scores on the self-report Geriatric Depression Scale (GDS)-3A, and a validated cutoff score (>0) on the informant-report Neuropsychiatric Inventory. Depression was assessed with strict and standard cutoffs on the GDS-12D, and fatigue with the Assessment of Quality of Life-6D. Multimorbidity (≥2 chronic conditions; computed with and without cardiovascular conditions), physical performance (walking speed, sit-to-stand, lateral stability, grip strength), adiposity (BMI, waist circumference), blood pressure, cholesterol and glucose were assessed. Results: Prevalence of apathy on the self-reported measure was 15.8 % (strict cutoff) or 48.9 % (standard). Informant-reported apathy was lower (2.9 %). Prevalence of self-reported depression was 5.9 % (strict cutoff) or 15.8 % (standard), and fatigue 9.8 %. Apathy overlapped very little with depression or fatigue (κ = .18, 95 % CI .14-.21). Apathy was associated with multimorbidity (even when excluding cardiovascular conditions), adiposity, fasting blood glucose level and physical performance, but not blood pressure or cholesterol. Conclusions: Apathy is more common than depression or fatigue in dementia-free older adults. It does not typically co-occur with these symptoms, but is accompanied by poorer physical health, including multimorbidity and metabolic dysregulation. Apathy may be relevant for public health and an important consideration in clinical care.

Monogenic causes of cerebral small vessel disease- models for vascular cognitive impairment and dementia?

Current Opinion In Psychiatry • January 22, 2025

Danit Saks, Perminder Sachdev

Objective: Recent advancements in molecular biomarkers and therapeutic options for Alzheimer's disease have brought into focus the need for greater progress in the second most common cause of dementia, vascular cognitive impairment and dementia (VCID). We examine how the study of monogenic causes of VCID has contributed to the understanding of its pathophysiology and potential biomarker and treatment research. Results: It is widely accepted that conditions which disrupt the cerebral small vessels contribute to vascular pathologies including stroke and cerebral microbleeds, ultimately leading to vascular cognitive impairment and dementia. Among these conditions are a range of monogenic small vessel diseases (SVDs) such as CADASIL, CARASIL, Fabry disease and COL4A-related disorders. Conclusions: This review indicates the importance of furthering research into monogenic SVDs in order to gain insight into the pathomechanisms of VCID more broadly. Monogenic conditions are easier to model than sporadic VCID and can serve as a guide for identifying biomarkers for diagnosis, monitoring and intervention outcomes.

The Role of Nutrition and Other Lifestyle Patterns in Mortality Risk in Older Adults with Multimorbidity.

Nutrients • January 14, 2025

Chao Dong, Karen Mather, Henry Brodaty, Perminder Sachdev, Julian Trollor, Fleur Harrison, Dana Bliuc, Rebecca Ivers, Joel Rhee, Zhaoli Dai

Background: Limited research has examined how older adults' lifestyles intersect with multimorbidity to influence mortality risk. Methods: In this community-dwelling prospective cohort, the Sydney Memory and Ageing Study, principal component analysis was used to identify lifestyle patterns using baseline self-reported data on nutrition, lifestyle factors, and social engagement activities. Multimorbidity was defined by self-reported physician diagnoses. Multivariable logistic regression was used to estimate odds ratios (ORs) for multimorbidity cross-sectionally, and Cox proportional hazards models were used to assess hazard ratios (HRs) for mortality risk longitudinally. Results: Of 895 participants (mean age: 78.2 years; 56.3% female) with complete lifestyle data, 597 had multimorbidity. Two distinct lifestyle patterns emerged: (i) a nutrition pattern characterised by higher intakes of protein, fibre, iron, zinc, magnesium, potassium, and folate, and (ii) an exercise-sleep-social pattern marked by weekly physical activities like bowling, bicycling, sleep quality (low snoring/sleepiness), and high social engagement. Neither pattern was associated with multimorbidity cross-sectionally. Over a median 5.8-year follow-up (n = 869; 140 deaths), participants in the upper tertiles for combined lifestyle pattern scores had a 20% lower mortality risk than those in the lowest tertile [adjusted HR: 0.80 (95% CI: 0.65-0.97); p-trend = 0.02]. This association was stronger in participants with multimorbidity, with a 29% lower risk [0.71 (0.56-0.89); p-trend = 0.01], likely due to multimorbidity modifying the relationship between nutrition and mortality risk (p-interaction < 0.05). While multimorbidity did not modify the relationship between the exercise-sleep-social pattern and risk of mortality, it was consistently associated with a 19-20% lower risk (p-trend < 0.03), regardless of the multimorbidity status. Conclusions: Older adults with multimorbidity may particularly benefit from adopting healthy lifestyles focusing on nutrition, physical activity, sleep quality, and social engagement to reduce their mortality risk.

Penetrance of neurodevelopmental copy number variants is associated with variations in cortical morphology.

Biological Psychiatry. Cognitive Neuroscience And Neuroimaging • January 07, 2025

Ana Silva, Ida Sønderby, George Kirov, Abdel Abdellaoui, Ingrid Agartz, David Ames, Nicola Armstrong, Eric Artiges, Tobias Banaschewski, Anne Bassett, Carrie Bearden, John Blangero, Rune Boen, Dorret Boomsma, Robin Bülow, Nancy Butcher, Vince Calhoun, Linda Campbell, Eva W Chow, Simone Ciufolini, Michael Craig, Benedicto Crespo Farroco, Adam Cunningham, Shareefa Dalvie, Eileen Daly, Paola Dazzan, Eco J De Geus, Greig De Zubicaray, Joanne Doherty, Gary Donohoe, Mark Drakesmith, Thomas Espeseth, Vincent Frouin, Hugh Garavan, David Glahn, Naomi Goodrich Hunsaker, Penny Gowland, Hans Grabe, Antoine Grigis, Maria Gudbrandsen, Boris Gutman, Jan Haavik, Asta Håberg, Jeremy Hall, Andreas Heinz, Sarah Hohmann, Jouke-jan Hottenga, Sébastien Jacquemont, Neda Jahanshad, Rachel Jonas, Derek Jones, Erik Jönsson, Sanne Koops, Kuldeep Kumar, Stephanie Le Hellard, Herve Lemaitre, Jingyu Liu, Astri Lundervold, Jean-luc Martinot, Karen Mather, Donna Mcdonald Mcginn, Katie Mcmahon, Allan Mcrae, Sarah Medland, Clara Moreau, Kieran Murphy, Declan Murphy, Robin Murray, Frauke Nees, Michael Owen, Marie-laure Paillère Martinot, Diimitri Orfanos, Tomas Paus, Luise Poustka, Tiago Marques, David Roalf, Perminder Sachdev, Freda Scheffler, J Schmitt, Gunter Schumann, Vidar Steen, Dan Stein, Lachlan Strike, Alexander Teumer, Anbupalam Thalamuthu, Sophia Thomopoulos, Diana Tordesillas Gutiérrez, Julian Trollor, Anne Uhlmann, Ariana Vajdi, Dennis Van Ent, Therese Van Amelsvoort, Marianne B Van Den Bree, Dennis Van Der Meer, Javier Vázquez Bourgon, Julio Villalón Reina, Uwe Völker, Henry Völzke, Jacob A Vorstman, Lars Westlye, Nigel Williams, Katharina Wittfeld, Margaret Wright, Paul Thompson, Ole Andreassen, David E Linden

Background: Copy number variants (CNVs) increase risk for neurodevelopmental conditions. The neurobiological mechanisms linking these high-risk genetic variants to clinical phenotypes are largely unknown. An important question is whether brain abnormalities in individuals carrying CNVs are associated with their degree of penetrance. Methods: We investigated if increased CNV-penetrance for schizophrenia and other developmental disorders was associated with variations in cortical and subcortical morphology. We pooled T1-weighted brain magnetic resonance imaging and genetic data from 22 cohorts from the ENIGMA-CNV consortium. In the main analyses, we included 9,268 individuals (aged 7 to 90 years, 54% females), from which we identified 398 carriers of 36 neurodevelopmental CNVs at 20 distinct loci. A secondary analysis was performed including additional neuroimaging data from the ENIGMA-22q consortium, including 274 carriers of the 22q11.2 deletion and 291 non-carriers. CNV-penetrance was estimated through penetrance scores that were previously generated from large cohorts of patients and controls. These scores represent the probability risk to develop either schizophrenia or other developmental disorders (including developmental delay, autism spectrum disorder and congenital malformations). Results: For both schizophrenia and developmental disorders, increased penetrance scores were associated with lower surface area in the cerebral cortex and lower intracranial volume. For both conditions, associations between CNV-penetrance scores and cortical surface area were strongest in regions of the occipital lobes, specifically in the cuneus and lingual gyrus. Conclusions: Our findings link global and regional cortical morphometric features with CNV-penetrance, providing new insights into neurobiological mechanisms of genetic risk for schizophrenia and other developmental disorders.

Frequently Asked Questions

What services does Dr Perminder S. Sachdev provide?
Dr Sachdev offers assessment and management for a wide range of neurological and mental health conditions, including Alzheimer's disease, dementia, memory loss, stroke-related issues, epilepsy, movement disorders, Parkinson's disease, major depression, bipolar disorder, ADHD, autism spectrum disorders, and various anaemias and metabolic concerns.
What conditions can I talk to Dr Sachdev about?
You can discuss conditions such as dementia, memory problems, epilepsy and seizures, Parkinson's disease, movement disorders, mood disorders like depression and bipolar disorder, ADHD, autism spectrum conditions, stroke and vascular issues, and related metabolic or nutritional concerns.
How do I book an appointment with Dr Sachdev?
To book an appointment, contact the Randwick practice at Barker Street, Randwick, NSW. The exact booking steps are provided by the clinic when you call or visit in person.
Is Dr Sachdev experienced with complex neurological and psychiatric conditions?
Yes. Dr Sachdev has over 40 years of experience and holds multiple qualifications in neurology and psychiatry, focusing on a broad range of neurological and mental health conditions.
What should I bring to my first visit?
Bring any relevant medical records, current medications, your concerns or symptoms, and any previous test results related to memory, mood, seizures, or neurological issues. The staff can advise if additional paperwork is needed.
Where is the clinic located?
The clinic is located on Barker Street in Randwick, NSW 2031, Australia.

Contact Information

Barker Street, Randwick, NSW 2031, Australia

Is this your profile?

Claim this profile →

Memberships

  • Member of the Order of Australia (AM)
  • Royal Australian and New Zealand College of Psychiatrists
  • Australian Academy of Health and Medical Sciences
  • Tourette Syndrome Association of Australia
  • VASCOG (International Society for Vascular Cognitive and Behavioural Disorders)